While the analytical rigor of HPLC systems remains foundational, the demands placed on service delivery have evolved. Today’s laboratories require more than reliable instruments; they… Read More »The Future of HPLC Support Is Integration Intelligence and Impact
The US analytical instruments industry has experienced a dramatic evolution in its trade balance over the past five years. What once was a period of… Read More »From Expansion to Uncertainty: The Evolving Trade Landscape for US Analytical Instruments
Data centers are among the most energy-intensive facilities in the world, with power demands varying based on size and workload. A small data center (5,000–20,000… Read More »Data Centers Fuel Demand for Process Gas Analyzers
The International Monetary Fund (IMF) released its April 2025 World Economic Outlook (WEO): A Critical Juncture amid Policy Shifts, soon after the US announced its latest round of tariffs—to be implemented nearly universally. The US began instituting new tariffs in February, and, although some trading partners responded with countermeasures, market responses were not particularly notable. However, with the April 2 announcement, tariff rates rose to the highest levels in about a century—a negative growth shock. Major equity indices experienced historic drops followed by a partial recovery after April 9, when a pause and some adjustments were announced. The unpredictable nature of these tariffs has had a negative impact on economic activity, and uncertainty, especially regarding trade policy, has soared.
Recent gradual improvements in the life science and analytical instrument markets continued in the fourth quarter of 2024.
Artificial intelligence, energy challenges, climate change and new blockbuster drugs (e.g., GLP-1) are key drivers for the lab and process market. However, the uncertainty of policies of newly elected administrations favoring deglobalization and deregulation have the potential to cause disruption, both in the analytical instruments industry and macroeconomically. As a result, our outlook for 2025 is
Artificial intelligence, energy challenges, climate change and new blockbuster drugs (e.g., GLP-1) are key drivers for the lab and process market. However, the uncertainty of policies of newly elected administrations favoring deglobalization and deregulation have the potential to cause disruption, both in the analytical instruments industry and macroeconomically. As a result, our outlook for 2025 is
The life science and analytical instrument markets showed continued slow recovery in the third quarter of 2024, as instrument sales and the Chinese economy both improved.
Since April of this year, the International Monetary Fund (IMF) has projected a consistent picture of the global economy, forecasting GDP growth of 3.2% in 2024 and 2025. However, in its October 2024 World Economic Outlook (WEO): Policy Pivot, Rising Threats, the IMF reports revisions to the outlook for a number of economies as well as changes in policy the institution deems necessary for “a smooth landing” and to increase growth potential.
For leading international publicly held life science and analytical instrument companies, the second quarter of 2024 showed signs of improvement, with some firms reporting results slightly better than expected.